Related Experiment Videos
Comorbidity and social phobia: clinical and epidemiological issues
1Department of Psychiatry, Hôpital Fernand Widal, Assistance Publique Hôpitaux de Paris, France.
International Clinical Psychopharmacology
|June 1, 1996
Summary
Social phobia frequently co-occurs with anxiety, mood disorders, and substance use. Understanding these comorbidities is crucial for effective social phobia assessment and treatment.
Area of Science:
- Psychiatry
- Epidemiology
- Clinical Psychology
Background:
- Social phobia (social anxiety disorder) is frequently observed alongside other mental health conditions.
- Existing research highlights significant comorbidity with anxiety and affective disorders.
- Less commonly, social phobia is associated with substance use disorders.
Purpose of the Study:
- To review the patterns of comorbidity associated with social phobia.
- To examine recent findings on the co-occurrence of social phobia with eating disorders, personality disorders, and medical conditions.
- To discuss the impact of comorbidity on patient outcomes and clinical practice.
Main Methods:
- Review of epidemiological surveys and clinical studies.
- Analysis of data on lifetime prevalence of co-occurring disorders.
- Synthesis of recent research on specific comorbidity patterns.
Main Results:
- Approximately 20% of individuals with social phobia have no other lifetime disorder.
- High rates of comorbidity exist with anxiety disorders and mood disorders.
- Comorbidity significantly impacts functional impairment, healthcare utilization, and suicidal ideation.
Conclusions:
- Comorbidity profoundly influences the course and severity of social phobia.
- Improved recognition and assessment of comorbid conditions are essential for effective treatment.
- Further research is needed to address the complex interplay of social phobia and co-occurring disorders.